Antihyperglycemic potential of Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle for in vitro intestinal glucose absorption in diabetic albino rats

Descripción del Articulo

Objective: To evaluate the antihyperglycemic potential of the Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle infusion for in vitro intestinal glucose absorption in Rattus norvegicus of the Holtzman strain with chemically-induced diabetes. Materials and methods: The study had an experimental a...

Descripción completa

Detalles Bibliográficos
Autor: Guevara-Vásquez, Ana María del Carmen
Formato: artículo
Fecha de Publicación:2019
Institución:Universidad de San Martín de Porres
Repositorio:Horizonte médico
Lenguaje:español
OAI Identifier:oai:horizontemedico.usmp.edu.pe:article/949
Enlace del recurso:https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/949
Nivel de acceso:acceso abierto
Materia:Hiperglicemia
Gentianella
Absorción intestinal
Diabetes mellitus
Hyperglycemia
Intestinal absorption
id REVHM_5c05df716152de9fa73abe516891ae54
oai_identifier_str oai:horizontemedico.usmp.edu.pe:article/949
network_acronym_str REVHM
network_name_str Horizonte médico
repository_id_str
dc.title.none.fl_str_mv Antihyperglycemic potential of Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle for in vitro intestinal glucose absorption in diabetic albino rats
Potencial antihiperglicémico de Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle en la absorción intestinal de glucosa in vitro en ratas albinas diabéticas
title Antihyperglycemic potential of Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle for in vitro intestinal glucose absorption in diabetic albino rats
spellingShingle Antihyperglycemic potential of Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle for in vitro intestinal glucose absorption in diabetic albino rats
Guevara-Vásquez, Ana María del Carmen
Hiperglicemia
Gentianella
Absorción intestinal
Diabetes mellitus
Hyperglycemia
Gentianella
Intestinal absorption
Diabetes mellitus
title_short Antihyperglycemic potential of Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle for in vitro intestinal glucose absorption in diabetic albino rats
title_full Antihyperglycemic potential of Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle for in vitro intestinal glucose absorption in diabetic albino rats
title_fullStr Antihyperglycemic potential of Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle for in vitro intestinal glucose absorption in diabetic albino rats
title_full_unstemmed Antihyperglycemic potential of Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle for in vitro intestinal glucose absorption in diabetic albino rats
title_sort Antihyperglycemic potential of Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle for in vitro intestinal glucose absorption in diabetic albino rats
dc.creator.none.fl_str_mv Guevara-Vásquez, Ana María del Carmen
author Guevara-Vásquez, Ana María del Carmen
author_facet Guevara-Vásquez, Ana María del Carmen
author_role author
dc.subject.none.fl_str_mv Hiperglicemia
Gentianella
Absorción intestinal
Diabetes mellitus
Hyperglycemia
Gentianella
Intestinal absorption
Diabetes mellitus
topic Hiperglicemia
Gentianella
Absorción intestinal
Diabetes mellitus
Hyperglycemia
Gentianella
Intestinal absorption
Diabetes mellitus
description Objective: To evaluate the antihyperglycemic potential of the Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle infusion for in vitro intestinal glucose absorption in Rattus norvegicus of the Holtzman strain with chemically-induced diabetes. Materials and methods: The study had an experimental and analytical design. A phytochemical screening of the whole plant was carried out. For the in vitro study, twenty male albino rats were induced with diabetes using alloxan monohydrate (Sigma-Aldrich, Saint Louis, MO, USA) at a dose of 120 mg/kg bw administered by intraperitoneal route, and then randomly distributed into two groups of ten albino rats each. After ten days, they were sacrificed to extract an intestinal segment using the everted intestinal sac technique, and measure the glucose transport and absorption. In the control group (everted intestines incubated in Krebs-Henseleit solution containing glucose) and the experimental group (intestines incubated in Krebs-Henseleit solution containing glucose plus the Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle infusion at 10% w/v), basal samples of fluids were taken from incubation, and then other samples were taken at 15, 30, 45 and 60 minutes to quantify the glucose from the mucous and serous compartments using the glucose oxidase enzymatic method. Results: Lower concentrations of absorbed glucose were observed in the intestinal serous compartment of the experimental group (G. gilgiana) with a statistically significant difference compared to the control group (p <0.05). Conclusions: The Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle infusion exhibits a significant antihyperglycemic potential by decreasing the in vitro intestinal glucose absorption in diabetic albino rats.
publishDate 2019
dc.date.none.fl_str_mv 2019-09-15
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/949
10.24265/horizmed.2019.v19n3.07
url https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/949
identifier_str_mv 10.24265/horizmed.2019.v19n3.07
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/949/625
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/949/661
dc.rights.none.fl_str_mv Derechos de autor 2019 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2019 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
dc.publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
dc.source.none.fl_str_mv Horizonte Médico (Lima); Vol. 19 No. 3 (2019): July - September; 40-48
Horizonte Médico (Lima); Vol. 19 Núm. 3 (2019): Julio - Setiembre; 40-48
Horizonte Médico (Lima); v. 19 n. 3 (2019): Julio - Setiembre; 40-48
2227-3530
1727-558X
10.24265/horizmed.2019.v19n3
reponame:Horizonte médico
instname:Universidad de San Martín de Porres
instacron:USMP
instname_str Universidad de San Martín de Porres
instacron_str USMP
institution USMP
reponame_str Horizonte médico
collection Horizonte médico
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1846623149196574720
spelling Antihyperglycemic potential of Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle for in vitro intestinal glucose absorption in diabetic albino ratsPotencial antihiperglicémico de Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle en la absorción intestinal de glucosa in vitro en ratas albinas diabéticasGuevara-Vásquez, Ana María del CarmenHiperglicemiaGentianellaAbsorción intestinalDiabetes mellitusHyperglycemiaGentianellaIntestinal absorptionDiabetes mellitusObjective: To evaluate the antihyperglycemic potential of the Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle infusion for in vitro intestinal glucose absorption in Rattus norvegicus of the Holtzman strain with chemically-induced diabetes. Materials and methods: The study had an experimental and analytical design. A phytochemical screening of the whole plant was carried out. For the in vitro study, twenty male albino rats were induced with diabetes using alloxan monohydrate (Sigma-Aldrich, Saint Louis, MO, USA) at a dose of 120 mg/kg bw administered by intraperitoneal route, and then randomly distributed into two groups of ten albino rats each. After ten days, they were sacrificed to extract an intestinal segment using the everted intestinal sac technique, and measure the glucose transport and absorption. In the control group (everted intestines incubated in Krebs-Henseleit solution containing glucose) and the experimental group (intestines incubated in Krebs-Henseleit solution containing glucose plus the Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle infusion at 10% w/v), basal samples of fluids were taken from incubation, and then other samples were taken at 15, 30, 45 and 60 minutes to quantify the glucose from the mucous and serous compartments using the glucose oxidase enzymatic method. Results: Lower concentrations of absorbed glucose were observed in the intestinal serous compartment of the experimental group (G. gilgiana) with a statistically significant difference compared to the control group (p <0.05). Conclusions: The Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle infusion exhibits a significant antihyperglycemic potential by decreasing the in vitro intestinal glucose absorption in diabetic albino rats.Objetivo: Evaluar el potencial antihiperglicémico de la infusión de Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle en la absorción intestinal de glucosa in vitro en Rattus norvegicus cepa Holtzman con diabetes inducida químicamente. Materiales y métodos: Estudio de tipo experimental y analítico. Se realizó el tamizaje fitoquímico de la planta. Para el estudio in vitro se utilizaron veinte ratas albinas machos, a las que se les indujo diabetes utilizando aloxano monohidratado (Sigma-Aldrich, Saint Louis, MO, EE. UU.) en dosis de 120 mg/kg p.c, vía intraperitoneal, y luego fueron distribuidas al azar en dos grupos de diez ratas albinas cada uno. Luego de diez días fueron sacrificados para extraerles un segmento intestinal con la técnica del saco intestinal evertido, y medir el transporte y absorción de glucosa. En el grupo control (intestinos evertidos incubados en solución Krebs-Henseleit glucosado) y en el grupo experimental (intestinos incubados en solución Krebs Henseleit glucosado más la infusión de Gentianella gilgiana al 10% p/v), se tomaron muestras basales de los líquidos de incubación, luego otras muestras a los 15, 30, 45 y 60 minutos para cuantificar la glucosa de los compartimentos mucoso y seroso mediante el método enzimático de la glucosa oxidasa. Resultados: Se evidenciaron menores concentraciones de glucosa absorbida en compartimento seroso intestinal del grupo experimental (G. gilgiana) con diferencia estadísticamente significativa respecto al control (p< 0,05). Conclusiones: La infusión de Gentianella gilgiana (Reimers) Fabris ex J.S. Pringle presenta potencial antihiperglicémico significativo que disminuye la absorción intestinal de glucosa in vitro en ratas albinas diabéticas.Universidad de San Martín de Porres. Facultad de Medicina Humana2019-09-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmlhttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/94910.24265/horizmed.2019.v19n3.07Horizonte Médico (Lima); Vol. 19 No. 3 (2019): July - September; 40-48Horizonte Médico (Lima); Vol. 19 Núm. 3 (2019): Julio - Setiembre; 40-48Horizonte Médico (Lima); v. 19 n. 3 (2019): Julio - Setiembre; 40-482227-35301727-558X10.24265/horizmed.2019.v19n3reponame:Horizonte médicoinstname:Universidad de San Martín de Porresinstacron:USMPspahttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/949/625https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/949/661Derechos de autor 2019 Horizonte Médico (Lima)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:horizontemedico.usmp.edu.pe:article/9492019-10-13T18:40:36Z
score 13.458049
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).